The FDA has issued a nationwide recall of over 2.5 million bottles of prescription eye drops due to contamination concerns involving a potential foreign substance. The recall affects commonly prescribed steroid eye drops, including prednisolone acetate. Patients are urged to check their medicine cabinets for the affected products as the recall raises serious questions about sterility and safety. With millions of bottles involved, this recall is categorized as a Class II recall, indicating a second-highest risk level for consumers. Lupin Pharmaceuticals, the manufacturer of the affected eye drops, has been identified as part of the recall. This alert comes amid growing scrutiny regarding the standards of sterility in pharmaceutical manufacturing.